Caricamento...
Polytherapeutic strategies with oncolytic virus–bortezomib and adjuvant NK cells in cancer treatment
Proteasome inhibition and oncolytic virotherapy are two emerging targeted cancer therapies. Bortezomib, a proteasome inhibitor, disrupts the degradation of proteins in the cell leading to accumulation of unfolded proteins inducing apoptosis. On the other hand, oncolytic virotherapy uses genetically...
Salvato in:
| Pubblicato in: | J R Soc Interface |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Royal Society
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7879760/ https://ncbi.nlm.nih.gov/pubmed/33402021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsif.2020.0669 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|